Jong-Kai Hsiao

Insulin‐Directed Synthesis of Fluorescent Gold Nanoclusters: Preservation of Insulin Bioactivity and Versatility in Cell Imaging

Fluorescent nanomaterials have received great attention and have been intensively studied, because of their unique optical and photophysical properties, as replacements for conventional organic dyes in optical cell imaging. Although semiconductor quantum dots show promising signals in biomedical imaging, their high inherent cytotoxicity and self-aggregation inside living cells fatally limit pragmatic biomedical applications. Fluorescent nanoclusters (NCs), in contrast, exhibit superior properties such as low toxicity and high biocompatibility. Among the various NCs, much effort has been dedicated to the study of fluorescent Au NCs. Au NCs carry quantum-mechanical properties when their sizes are comparable to or smaller than the Fermi wavelength (ca. 1 nm) of conductive electrons. The fluorescent Au NCs, with their ultrafine size, do not disturb the biological functions of the labeled bioentities; therefore, there is great potential to develop Au NCs as a new luminescent label. For example, Lin et al. successfully used water-soluble fluorescent Au NCs capped with dihydrolipoic acid (AuNC@DHLA) and modified with polyethylene glycol (PEG), bovine serum albumin (BSA), and streptavidin for cell bioimaging. Compared with organic-monolayer-protected Au NCs, the usage of proteins as a green-chemical reducing and stabilizing agent is advantageous because their complex 3D structures can withstand a wide range of pH conditions. Accordingly, Au NC synthesis with BSA and lysozyme has been reported and applied to several devices, such as nanosensors of Hg, CN , and H2O2. [12] Very recently, through the conjugation of BSA–Au NCs to folic acid, targetspecific detection of cancer-cell imaging has been demonstrated. Also, BSA–Au NCs have been applied in MDAMB-45 and HeLa tumor xenograft model imaging. Nevertheless, up to this stage, there has been a lack of reports on bioactive protein-directed fluorescent Au NCs that can still preserve their own biological role. Conversely, using Au nanoparticles encapsulated in certain enzymes, several reports claimed significant changes of enzymatic functionality. The goal of this project is thus to search for a bioactive protein to exploit as a template to direct the growth of fluorescent Au NCs. The resulting protein–Au NC nanocomposites are able to retain bioactivity, so that the associated biological role can be pursued by various imaging techniques. Among a number of proteins of vital importance, insulin is of prime interest. Insulin is a polypeptide hormone comprising only 51 amino acids. Its function primarily lies in the regulation of insulin-responsive tissues and it is also directly/indirectly related to many diseases, including diabetes, Alzheimer s disease, obesity, and aging. Its signaling pathway controls the growth of an organism, and hence exerts a profound influence on metabolism and reproduction. Herein, we report for the first time the synthesis of fluorescent Au NCs by using insulin as a template. The resulting insulin–Au NCs exhibit intense red fluorescence maximized at 670 nm and, more importantly, retain their bioactivity and biocompatibility. Several key experiments have been performed in vitro and/or in vivo to assess their viability and versatility. Detailed synthetic procedures are elaborated in the Supporting Information. In brief, by mixing insulin and HAuCl4 in Na3PO4 buffer by continuously stirring at 4 8C for 12 h, reddish luminescent insulin–Au NCs were readily prepared. The crude product was then purified by centrifugal filtration (4000g) for 30 min with a cutoff of 5 kDa to obtain the insulin–Au NCs for subsequent applications. The absorption and photoluminescence emission spectra of insulin–Au NCs are shown in Figure 1. The emission quantum yield Ff was determined to be 0.07, with observed lifetimes fitted to be 439 ns (4%) and 2041 ns (96%). The inset of Figure 1 displays a high-resolution transmission electron microscopy (HRTEM) image of insulin–Au NCs. From the respective histograms, the as-prepared insulin– Au NCs revealed a spherical shape and good size uniformity (for size distribution, see Figure S1 in the Supporting Information). The diameters of insulin–Au NCs, upon averaging over 100 particles, were calculated to be (0.92 0.03) nm (mainly for Au NCs). The hydrodynamic radii of [*] C.-L. Liu, Y.-H. Hsiao, Dr. C.-W. Lai, C.-W. Shih, Y.-K. Peng, Dr. K.-C. Tang, H.-W. Chang, Prof. P.-T. Chou Department of Chemistry, National Taiwan University 1, Section 4, Roosevelt Road, Taipei 10617 (Taiwan) Fax: (+886)2-369-5208 E-mail: chop@ntu.edu.tw

Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy.

Highly uniform Fe3O4/SiO2 core/shell nanoparticles functionalized by phosphorescent iridium complexes (Ir) have been strategically designed and synthesized. The Fe3O4/SiO2(Ir) nanocomposite demonstrates its versatility in various applications: the magnetic core provides the capability for magnetic resonance imaging and the great enhancement of the spin-orbit coupling in the iridium complex makes it well suited for phosphorescent labeling and simultaneous singlet oxygen generation to induce apoptosis.

Mesoporous Silica Nanoparticles as a Delivery System of Gadolinium for Effective Human Stem Cell Tracking

The progress of using gadolinium (Gd)-based nanoparticles in cellular tracking lags behind that of superparamagnetic iron oxide (SPIO) nanoparticles in magnetic resonance imaging (MRI). Here, dual functional Gd-fluorescein isothiocyanate mesoporous silica nanoparticles (Gd-Dye@MSN) that possess green fluorescence and paramagnetism are developed in order to evaluate their potential as effective T1-enhancing trackers for human mesenchymal stem cells (hMSCs). hMSCs are labeled efficiently with Gd-Dye@MSN via endocytosis. Labeled hMSCs are unaffected in their viability, proliferation, and differentiation capacities into adipocytes, osteocytes, and chondrocytes, which can still be readily MRI detected. Imaging, with a clinical 1.5-T MRI system and a low incubation dosage of Gd, low detection cell numbers, and short incubation times is demonstrated on both loaded cells and hMSC-injected mouse brains. This study shows that the advantages of biocompatibility, durability, high internalizing efficiency, and pore architecture make MSNs an ideal vector of T1-agent for stem-cell tracking with MRI.

The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles

Superparamagnetic iron oxide (SPIO) nanoparticles are very useful in cell imaging; meanwhile, however, biosafety concerns associated with their use, especially on therapeutic stem cells, have arisen. Most studies of biosafety issues focus on whether the nanoparticles have deleterious effects. Here, we report that Ferucarbotran, an ionic SPIO, is not toxic to human mesenchymal stem cells (hMSCs) under the conditions of these experiments but instead increases cell growth. Ferucarbotran-promoted cell growth is due to its ability to diminish intracellular H2O2 through intrinsic peroxidase-like activity. Also, Ferucarbotran can accelerate cell cycle progression, which may be mediated by the free iron (Fe) released from lysosomal degradation and involves the alteration of Fe on the expression of the protein regulators of the cell cycle.

The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells.

Superparamagnetic iron oxide (SPIO) nanoparticles are very useful for monitoring cell trafficking in vivo and distinguish whether cellular regeneration originated from an exogenous cell source, which is a key issue for developing successful stem cell therapies. However, the impact of SPIO labeling on stem cell behavior remains uncertain. Here, we show the inhibitory effect of Ferucarbotran, an ionic SPIO, on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Ferucarbotran caused a dose-dependent inhibition of osteogenic differentiation, abolished the differentiation at high concentration, promoted cell migration, and activated the signaling molecules, beta-catenin, a cancer/testis antigen, SSX, and matrix metalloproteinase 2 (MMP2). An iron chelator, desferrioxamine, suppressed all the above Ferucarbotran-induced actions, demonstrating an important role of free iron in the inhibition of osteogenic differentiation that is mediated by the promotion of cell mobilization, involving the activation of a specific signaling pathway.

A New and Facile Method To Prepare Uniform Hollow MnO/Functionalized mSiO2 Core/Shell Nanocomposites

Trifunctional uniform nanoparticles comprising a manganese nanocrystal core and a functionalized mesoporous silica shell (MnO@mSiO(2)(Ir)@PEG, where Ir is an emissive iridium complex and PEG is polyethylene glycol) have been strategically designed and synthesized. The T(1) signal can be optimized by forming hollow core (H-MnO@mSiO(2)(Ir)@PEG) via a novel and facile etching process, for which the mechanism has been discussed in detail. Systematic investigation on correlation for longitudinal relaxation (T(1)) versus core shapes and shell silica porosity of the nanocomposites (MnO, H-MnO, MnO@SiO(2), MnO@mSiO(2), H-MnO@mSiO(2)) has been carried out. The results show that the worm-like nanochannels in the mesoporous silica shell not only increase water permeability to the interior hollow manganese oxide core for T(1) signal but also enhance photodynamic therapy (PDT) efficacy by enabling the free diffusion of oxygen. Notably, the H-MnO@mSiO(2)(Ir)@PEG nanocomposite with promising r(1) relaxivity demonstrates its versatility, in which the magnetic core provides the capability for magnetic resonance imaging, while the simultaneous red phosphorescence and singlet oxygen generation from the Ir complex are capable of providing optical imaging and inducing apoptosis, respectively.

Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: Cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level

The purpose of this work was to evaluate the efficacy of labeling human mesenchymal stem cells (hMSCs) by ionic superparamagnetic iron oxide (SPIO) without a transfection agent and verifying its capability to be detected with clinical 1.5 T magnetic resonance (MR) at the single‐cell level. Human hMSCs were incubated for 24 h with an ionic SPIO, Ferucarbotran. The labeling efficiency of hMSCs was determined by iron content measurement spectrophotometrically, and the influence of labeling on cell behavior was ascertained by examination of cell viability using the trypan blue exclusion method, cell proliferation analysis using MTT (3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide) assay, mitochondrial membrane potential (MMP) change, differentiation capacity, and reactive oxygen species (ROS) production measured by dichlorofluorescein diacetate (DCFDA) fluorescent probe. Labeled hMSCs were scanned under 1.5 T MRI with three‐dimensional (3D) and two‐dimensional (2D) T2‐weighted gradient echo (GRE) pulse sequences. Human hMSC labeling without transfection agent was efficient. The iron content in hMSCs was 23.4 pg Fe/cell. No significant change was found in viability, proliferation, MMP change, ROS production, or differentiation capacity. About 45.2% of the hMSCs could be detected using 1.5 T MRI at the single cell level with 3D GRE and four repetitions. Magn Reson Med 58:717–724, 2007.

Macrophage physiological function after superparamagnetic iron oxide labeling.

Our goal was to analyze the changes in morphology and physiological function (phagocytosis, migratory capabilities, humoral and cellular response, and nitric oxide secretion) of murine macrophages after labeling with a clinically used superparamagnetic iron oxide (SPIO), ferucarbotran. In SPIO‐treated macrophages, nanoparticles were taken up in the cytoplasm and accumulated in a membrane‐bound organelle. Macrophage proliferation and viability were not modified after SPIO labeling. Phagocytic function decreased after labeling with only 10 µg Fe/mL SPIO, whereas other functions including migration and production of tumor necrosis factor‐α and nitric oxide increased at the highest SPIO concentration (100 µg Fe/mL). Copyright

Antiferromagnetic iron nanocolloids: a new generation in vivo T1 MRI contrast agent.

A novel T1 agent, antiferromagnetic α-iron oxide-hydroxide (α-FeOOH) nanocolloids with a diameter of 2-3 nm, has been successfully prepared. These nanocolloids, together with a post synthetic strategy performed in mesoporous silica, are a great improvement over the low T1-weighted contrast common in traditional magnetic silica nanocomposites. The intrinsic antiferromagnetic goethite (α-FeOOH) shows very low magnetization (M(z)) of 0.05 emu g(-1) at H = 2 T at 300 K (0.0006 emu g(-1) for FeOOH/WMSN-PEG), which is 2 orders of magnitude smaller than any current ultrasmall iron oxide NPs (>5 emu g(-1)) reported to date, hence ensuring the low r2 (∝ Mz) (7.64 mM(-1) s(-1)) and r2/r1 ratio (2.03) at 4.7 T. These biodegradable α-FeOOH nanocolloids also demonstrate excellent in vitro cellular imaging and in vivo MR vascular and urinary trace imaging capability with outstanding biocompatibility, which is exceptionally well secreted by the kidney and not the liver as with most nanoparticles, opening up a new avenue for designing powerful antiferromagnetic iron T1 contrast agents.

N-butyl Cyanoacrylate Embolization as the Primary Treatment of Acute Hemodynamically Unstable Lower Gastrointestinal Hemorrhage

PURPOSE To evaluate N-butyl cyanoacrylate (NBCA) embolization as the primary treatment for patients with severe and acute hemodynamically unstable lower gastrointestinal bleeding. MATERIALS AND METHODS Twenty-seven patients with acute, unstable hemodynamics caused by lower gastrointestinal bleeding underwent therapeutic NBCA microcatheter embolization over a period of 27 months. The inclusion criteria were hematochezia or melena and hypotension refractory to conservative treatment and requiring blood transfusion. Bleeding was localized to the rectum, colon, or small intestine in all nine such cases. Fifteen patients had severe underlying comorbidities, including sepsis, respiratory failure, malignancy, or renal failure. RESULTS The procedure was technically successful in all patients. Twenty-six patients were treated solely with NBCA, and one required microcoil embolization. Embolization was performed at the level of the arteria recta or as close as possible to the point of bleeding. Immediate hemostasis occurred in all cases. Four patients experienced repeat hemorrhage, one of whom died. The other three were treated successfully with repeat NBCA embolization. None of the surviving patients had evidence of bowel ischemia. In addition, none of the patients with severe underlying disease died during the follow-up period (range, 3 mo to 2 y). CONCLUSIONS The present findings suggest that NBCA embolization may be a safe alternative treatment for the management of lower gastrointestinal bleeding. Further studies are warranted to confirm the findings.